Researchers retrospectively reviewed data regarding children and youths who were beginning treatment with antipsychotic vs control medications to assess their risks for unexpected death.

The co-occurrence of obesity and mood disorders increases the risk for physical comorbidities, poor mental health and psychological well-being, and less healthy behaviors.

Although treatment as usual for psychosis is guideline-congruent and well implemented, there appears to be no added value for adjunct cognitive behavioral therapy for social activation, according to the results of a study from the Netherlands.

Symptoms of depression and PTSD may be increased in veterans with insomnia, which may be associated with an increased risk for suicidal behavior.

In the Phase 3 JET8 study (N=318), patients underwent a circadian challenge of 8 hours in advance to their usual bedtime.

Investigators determined that although psychotropic medication review may reduce the number of prescriptions dispensed, clinical and economic benefits have yet to be identified; therefore, they do not recommend medication review as part of routine care.

In this study of older patients with schizophrenia, investigators examined the temporal fluctuations that occur with awareness of mental illness, and related factors that influence illness awareness.

Alprazolam was found to be the most commonly misused benzodiazepine.

An NDA has been submitted to the FDA for a transdermal patch formulation of asenapine for the treatment of schizophrenia.

Investigators sought to determine clinical characteristics associated with an increased risk for mild cognitive impairment in older adults with depression.